Grützmacher P - Search Results

1

In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.

Ganser A, Bergmann M, Völkers B, Grützmacher P, Scigalla P, Hoelzer D. Ganser A, et al. Among authors: grutzmacher p. Exp Hematol. 1989 Jun;17(5):433-5. Exp Hematol. 1989. PMID: 2714423

2

Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients.

Löw-Friedrich I, Grützmacher P, März W, Bergmann M, Schoeppe W. Löw-Friedrich I, et al. Among authors: grutzmacher p. Am J Nephrol. 1991;11(1):54-60. doi: 10.1159/000168273. Am J Nephrol. 1991. PMID: 1828650

3

Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.

Grützmacher P, Ehmer B, Limbach J, Messinger D, Kulbe KD, Scigalla P. Grützmacher P, et al. Blood Purif. 1990;8(5):279-84. doi: 10.1159/000169979. Blood Purif. 1990. PMID: 2091687 Clinical Trial.

4

Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.

Löw-Friedrich I, Grützmacher P, März W, Bergmann M, Schoeppe W. Löw-Friedrich I, et al. Among authors: grutzmacher p. Blood Purif. 1990;8(5):272-8. doi: 10.1159/000169978. Blood Purif. 1990. PMID: 2151114

5

Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.

Löw I, Grützmacher P, Bergmann M, Schoeppe W. Löw I, et al. Among authors: grutzmacher p. Clin Nephrol. 1989 Jan;31(1):26-30. Clin Nephrol. 1989. PMID: 2521587

6

In vitro and in vivo effects of recombinant human erythropoietin on human hemopoietic progenitor cells.

Ganser A, Bergmann M, Völkers B, Grützmacher P, Hoelzer D. Ganser A, et al. Among authors: grutzmacher p. Contrib Nephrol. 1988;66:123-30. Contrib Nephrol. 1988. PMID: 3292145 Clinical Trial. No abstract available.

7

Iron metabolism under rEPO therapy in patients on maintenance hemodialysis.

Bergmann M, Grützmacher P, Heuser J, Kaltwasser JP. Bergmann M, et al. Among authors: grutzmacher p. Int J Artif Organs. 1990 Feb;13(2):109-12. Int J Artif Organs. 1990. PMID: 2347653

8

Variations of recombinant human erythropoietin application in hemodialysis patients.

Bommer J, Samtleben W, Koch KM, Baldamus CA, Grützmacher P, Scigalla P. Bommer J, et al. Among authors: grutzmacher p. Contrib Nephrol. 1989;76:149-56; discussion 156-8. doi: 10.1159/000417891. Contrib Nephrol. 1989. PMID: 2684517 Clinical Trial. No abstract available.

9

Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin.

Grützmacher P, Ehmer B, Messinger D, Kulbe KD, Scigalla P. Grützmacher P, et al. Contrib Nephrol. 1989;76:315-21; discussion 322-3. doi: 10.1159/000417908. Contrib Nephrol. 1989. PMID: 2684530 Clinical Trial. No abstract available.

10

Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.

Grützmacher P, Bergmann M, Weinreich T, Nattermann U, Reimers E, Pollok M. Grützmacher P, et al. Contrib Nephrol. 1988;66:104-13. doi: 10.1159/000416008. Contrib Nephrol. 1988. PMID: 3292143 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters